Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Multi

Banque St-Olive BSO Bio Sante

+ Add to Watchlist

BSOBISA:FP

830.59 EUR 7.46 0.89%

As of 01:59:30 ET on 01/27/2015.

Snapshot for Banque St-Olive BSO Bio Sante (BSOBISA)

Year To Date: +11.54% 3-Month: +23.70% 3-Year: +32.20% 52-Week Range: 526.69 - 838.05
1-Month: +12.72% 1-Year: +50.00% 5-Year: +23.90% Beta vs MXWOEPB: -

Mutual Fund Chart for BSOBISA

No chart data available.
  • BSOBISA:FP 830.59
  • 1M
  • 1Y
Interactive BSOBISA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BSOBISA

BSO Bio Sante is an open-end fund registered in France. The objective of the Fund is to provide capital appreciation. The Fund invests at least 60 percent of its assets in stocks of european and north american countries related to the health and biotechnology sectors.

Inception Date: 12-13-1996 Telephone: 33-4-72-82-10-10
Managers: -
Web Site: www.bsosoc.com

Fundamentals for BSOBISA

NAV (on 2015-01-27) 830.59
Assets (M) (on 2015-01-27) 128.92
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BSOBISA

No dividends reported

Fees & Expenses for BSOBISA

Front Load 4.00
Back Load 4.00
Current Mgmt Fee 2.00
Redemption Fee 4.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BSOBISA

Filing Date: 11/28/2014
Name Position Value % of Total
Celgene Corp 43,707 3,996,000 3.700%
Gilead Sciences Inc 45,516 3,672,000 3.400%
Receptos Inc 32,756 3,564,000 3.300%
Isis Pharmaceuticals Inc 75,201 3,132,000 2.900%
Tetraphase Pharmaceuticals Inc 142,437 3,024,000 2.800%
Regeneron Pharmaceuticals Inc 8,069 2,700,000 2.500%
Regulus Therapeutics Inc 171,993 2,592,000 2.400%
Innate Pharma SA 280,995 2,484,000 2.300%
Agios Pharmaceuticals Inc 30,640 2,484,000 2.300%
Biogen Idec Inc 10,039 2,484,000 2.300%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil